CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab

被引:14
|
作者
Lentsch, Simone de Vries [1 ]
Al-Hassany, Linda [2 ]
Ferrari, Michel Dominique [1 ]
Terwindt, Gisela Marie [1 ]
MaassenVanDenBrink, Antoinette [2 ]
机构
[1] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands
[2] Erasmus MC, Div Vasc Med & Pharmacol, Dept Internal Med, Rotterdam, Netherlands
来源
基金
荷兰研究理事会;
关键词
migraine; trigeminal nerve;
D O I
10.1136/jnnp-2021-327992
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:911 / 912
页数:2
相关论文
共 50 条
  • [1] Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab
    Garcia-Estevez, Daniel A.
    Juanatey-Garcia, Ana
    Rodriguez-Garrido, Juan
    Sabbagh-Casado, Nabil
    Jaime-Sanchez, Gabriel
    Blanco-Garcia, Laura
    [J]. REVISTA DE NEUROLOGIA, 2024, 78 (10) : 293 - 294
  • [2] The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine
    Edvinsson, Lars
    [J]. HEADACHE, 2017, 57 : 47 - 55
  • [3] Serum CGRP in migraine patients using erenumab as preventive treatment
    Lentsch, Simone de Vries
    Garrelds, Ingrid M.
    Danser, A. H. Jan
    Terwindt, Gisela M.
    MaassenVanDenBrink, Antoinette
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [4] Serum CGRP in migraine patients using erenumab as preventive treatment
    Simone de Vries Lentsch
    Ingrid M. Garrelds
    A. H. Jan Danser
    Gisela M. Terwindt
    Antoinette MaassenVanDenBrink
    [J]. The Journal of Headache and Pain, 2022, 23
  • [5] THE STIMULATION OF TRPA1 CHANNEL ON THE TRIGEMINOVASCULAR SYSTEM ACTIVATES THE NOCICEPTIVE PATHWAY AND ELICITS CGRP-MEDIATED VASODILATATION
    Nassini, R.
    Benemei, S.
    Materazzi, S.
    De Siena, G.
    Pedretti, P.
    Mancini, F.
    Trevisani, M.
    Patacchini, R.
    Geppetti, P.
    [J]. NEUROPEPTIDES, 2010, 44 (06) : 536 - 536
  • [6] CGRP-mediated cardiovascular effect of nitroglycerin
    Li, YJ
    Du, YH
    [J]. MEDICAL HYPOTHESES, 2003, 60 (05) : 693 - 698
  • [7] Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab
    Al-Khazali, Haidar M.
    Ashina, Hakan
    Christensen, Rune Hackert
    Wiggers, Astrid
    Rose, Kathrine
    Iljazi, Afrim
    Amin, Faisal Mohammad
    Ashina, Messoud
    Snellman, Josefin
    Maio-Twofoot, Tina
    Schytz, Henrik W.
    [J]. CEPHALALGIA, 2024, 44 (06)
  • [8] Improvement in Migraine Pain Severity in Patients Treated with Erenumab
    Lipton, R. B.
    Dodick, D. W.
    Kudrow, D.
    Reuter, U.
    Tenenbaum, N.
    Richards, S.
    Lima, G. Paiva Da Silva
    Chou, D. E.
    Mikol, D. D.
    [J]. HEADACHE, 2019, 59 : 102 - 102
  • [9] Capsaicin-induced CGRP-mediated vasodilatation of the human skin: influence of gender, female hormones and migraine
    SGG Vermeersch
    P Frederiks
    A Maassen VandenBrink
    J de Hoon
    [J]. The Journal of Headache and Pain, 2013, 14
  • [10] CGRP-mediated vasodilation in the bronchial circulation of dogs.
    Pisarri, TE
    [J]. FASEB JOURNAL, 1997, 11 (03): : 2827 - 2827